Growth plate regulation and osteochondroma formation: Insights from tracing proteoglycans in zebrafish models and human cartilage

Journal of Pathology

Volumn 224, Issue 2, 2011, Pages 160-168

  De Andrea, Carlos E ^a   Prins, Frans A ^a   Wiweger, Malgorzata I ^a   Hogendoorn, Pancras Cw ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

bone tumours; exostosis; gradients; growth plate; heparan sulphate; osteochondroma; proteoglycans; zebrafish

Indexed keywords

GLYCOSAMINOGLYCAN; HEPARAN SULFATE; PROTEOGLYCAN;

ARTICLE; CARCINOGENESIS; CARTILAGE MATRIX; GENE MUTATION; GROWTH PLATE; HUMAN; HUMAN CELL; HUMAN TISSUE; NONHUMAN; OSTEOCHONDROMA; PHENOTYPE; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEIN SYNTHESIS; SULFATION; ZEBRA FISH;

ADOLESCENT; ADULT; ANIMALS; BONE NEOPLASMS; CHONDROCYTES; DISEASE MODELS, ANIMAL; GROWTH PLATE; HUMANS; MICROSCOPY, ELECTRON; MICROSCOPY, PHASE-CONTRAST; MUTATION; N-ACETYLGLUCOSAMINYLTRANSFERASES; NEOPLASM PROTEINS; OSTEOCHONDROMA; PROTEOGLYCANS; ZEBRAFISH;

EID: 79955805644     PISSN: 00223417     EISSN: 10969896     Source Type: Journal    
DOI: 10.1002/path.2886     Document Type: Article

References (38)

1. Yan D, Lin X,. Shaping morphogen gradients by proteoglycans. Cold Spring Harbor Perspect Biol 2009; 1: a002493.
2. Hacker U, Nybakken K, Perrimon N,. Heparan sulphate proteoglycans: the sweet side of development. Nat Rev Mol Cell Biol 2005; 6: 530-541. (Pubitemid 40943044)
3. Bulow HE, Hobert O,. The molecular diversity of glycosaminoglycans shapes animal development. Annu Rev Cell Dev Biol 2006; 22: 375-407.
4. Kronenberg HM,. Developmental regulation of the growth plate. Nature 2003; 423: 332-336. (Pubitemid 40852707)
5. Wu Y, Belenkaya TY, Lin X,. Dual roles of Drosophila glypican Dally-like in Wingless/Wnt signaling and distribution. Methods Enzymol 2010; 480: 33-50.
6. Cortes M, Baria AT, Schwartz NB,. Sulfation of chondroitin sulfate proteoglycans is necessary for proper Indian hedgehog signaling in the developing growth plate. Development 2009; 136: 1697-1706.
7. Bovee JVMG, Hogendoorn PCW, Wunder JS, et al., Cartilage tumours and bone development: molecular pathology and possible therapeutic targets. Nat Rev Cancer 2010; 10: 481-488.
8. Hameetman L, Szuhai K, Yavas A, et al., The role of EXT1 in non hereditary osteochondroma: identification of homozygous deletions. J Natl Cancer Inst 2007; 99: 396-406. (Pubitemid 47073483)
9. Wuyts W, Van Hul W,. Molecular basis of multiple exostoses: mutations in the EXT1 and EXT2 genes. Hum Mutat 2000; 15: 220-227. (Pubitemid 30132156)
10. Bovee JVMG, Cleton-Jansen AM, Wuyts W, et al., EXT-mutation analysis and loss of heterozygosity in sporadic and hereditary osteochondromas and secondary chondrosarcomas. Am J Hum Genet 1999; 65: 689-698. (Pubitemid 30468713)
11. McCormick C, Leduc Y, Martindale D, et al., The putative tumour suppressor EXT1 alters the expression of cell-surface heparan sulfate. Nat Genet 1998; 19: 158-161. (Pubitemid 28248797)
12. Zak BM, Crawford BE, Esko JD,. Hereditary multiple exostoses and heparan sulfate polymerization. Biochim Biophys Acta 2002; 1573: 346-355. (Pubitemid 35335443)
13. van den, Berg H, Kroon HM, Slaar A, et al., Incidence of biopsy-proven bone tumors in children: a report based on the Dutch pathology registration 'PALGA'. J Pediatr Orthop 2008; 28: 29-35. (Pubitemid 351628188)
14. Khurana J, Abdul-Karim F, Bovée JVMG,. Osteochondroma. In World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of Soft Tissue and Bone, Fletcher CDM, Unni KK, Mertens F, (eds). IARC Press: Lyon, France, 2002; 234-236.
15. Stieber JR, Dormans JP,. Manifestations of hereditary multiple exostoses. J Am Acad Orthop Surg 2005; 13: 110-120.
16. Osterholm C, Barczyk MM, Busse M, et al., Mutation in the heparan sulfate biosynthesis enzyme EXT1 influences growth factor signaling and fibroblast interactions with the extracellular matrix. J Biol Chem 2009; 284: 34935-34943.
17. Clément A, Wiweger M, von der Hardt S, et al., Regulation of zebrafish skeletogenesis by ext2/dackel and papst1/pinscher. PLoS Genet 2008; 4: e1000136.
18. Reijnders CM, Waaijer CJ, Hamilton A, et al., No haploinsufficiency but loss of heterozygosity for EXT in multiple osteochondromas. Am J Pathol 2010; 177: 1946-1957.
19. Zuntini M, Pedrini E, Parra A, et al., Genetic models of osteochondroma onset and neoplastic progression: evidence for mechanisms alternative to EXT genes inactivation. Oncogene 2010; 29: 3827-3834.
20. Jones KB, Piombo V, Searby C, et al., A mouse model of osteochondromagenesis from clonal inactivation of Ext1 in chondrocytes. Proc Natl Acad Sci USA 2010; 107: 2054-2059.
21. Matsumoto K, Irie F, Mackem S, et al., A mouse model of chondrocyte-specific somatic mutation reveals a role for Ext1 loss of heterozygosity in multiple hereditary exostoses. Proc Natl Acad Sci USA 2010; 107: 10932-10937.
22. Hilton MJ, Gutierrez L, Martinez DA, et al., EXT1 regulates chondrocyte proliferation and differentiation during endochondral bone development. Bone 2005; 36: 379-386.
23. de Andrea CE, Wiweger M, Prins F, et al., Primary cilia organization reflects polarity in the growth plate and implies loss of polarity and mosaicism in osteochondroma. Lab Invest 2010; 90: 1091-1101.
24. Vernier RL, Klein DJ, Sisson SP, et al., Heparan sulfate-rich anionic sites in the human glomerular basement membrane. Decreased concentration in congenital nephrotic syndrome. N Engl J Med 1983; 309: 1001-1009. (Pubitemid 13014769)
25. Hogendoorn PCW, De Heer E, Weening JJ, et al., Glomerular capillary wall charge and antibody binding in passive Heymann nephritis. J Lab Clin Med 1988; 111: 150-157. (Pubitemid 18074317)
26. Sauren YM, Mieremet RH, Groot CG, et al., Polyethyleneimine as a contrast agent for ultrastructural localization and characterization of proteoglycans in the matrix of cartilage and bone. J Histochem Cytochem 1991; 39: 331-340.
27. Schurer JW, Kalicharan D, Hoedemaeker PJ, et al., The use of polyethyleneimine for demonstration of anionic sites in basement membranes and collagen fibrils. J Histochem Cytochem 1978; 26: 688-689. (Pubitemid 9012059)
28. Kimmel CB, Ballard WW, Kimmel SR, et al., Stages of embryonic development of the zebrafish. Dev Dyn 1995; 203: 253-310.
29. Wiweger MI, Avramut C, de Andrea CE, et al., Cartilage ultrastructure in proteoglycan-deficient zebrafish mutants brings to light new candidate genes for human skeletal disorders. J Pathol 2010; (in press).
30. Ueda H, Toriumi H, Leng CG, et al., A histochemical study of anionic sites in the intermediate layer of rat femoral cartilage using polyethyleneimine at different pH levels. Histochem J 1997; 29: 617-624. (Pubitemid 27431490)
31. Prins FA, Diemen-Steenvoorde R, Bonnet J, et al., Reflection contrast microscopy of ultrathin sections in immunocytochemical localization studies: a versatile technique bridging electron microscopy with light microscopy. Histochem 1993; 99: 417-425. (Pubitemid 23208090)
32. Sissoeff I, Grisvard J, Guille E,. Studies on metal ions-DNA interactions: specific behaviour of reiterative DNA sequences. Prog Biophys Mol Biol 1976; 31: 165-199.
33. Sauren YM, Mieremet RH, Lafeber FP, et al., Changes in proteoglycans of ageing and osteoarthritic human articular cartilage: an electron microscopic study with polyethyleneimine. Anat Rec 1994; 240: 208-216. (Pubitemid 24299101)
34. Heinegard D,. Proteoglycans and moreâfrom molecules to biology. Int J Exp Pathol 2009; 90: 575-586.
35. Willems SM, Wiweger M, Frans Graadt van Roggen J, et al., Running GAGs: myxoid matrix revisited. What's in it for the pathologist? Virchow Arch 2009; 456: 181-192.
36. Heinegard D, Saxne T,. The role of the cartilage matrix in osteoarthritis. Nat Rev Rheumatol 2011; 7: 50-56.
37. Esko JD, Kimata K, Lindahl U,. Proteoglycans and sulfated glycosaminoglycans. In Essentials of Glycobiology, 2nd edn, Varki A, Cummings RD, Esko JD, et al,. (eds). Cold Spring Harbor Laboratory Press: Cold Spring Harbor, NY, 2009.
38. Bianco P, Kuznetsov SA, Riminucci M, et al., Reproduction of human fibrous dysplasia of bone in immunocompromised mice by transplanted mosaics of normal and Gsα-mutated skeletal progenitor cells. J Clin Invest 1998; 101: 1737-1744. (Pubitemid 28198504)